These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8008667)

  • 1. [Chemotaxis and spontaneous migration of neutrophil leukocytes from patients with diabetes].
    Debczyński W; Pietruska Z
    Pol Tyg Lek; 1994 Jan 3-17; 49(1-3):11-3. PubMed ID: 8008667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
    Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
    Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired leucocyte functions in diabetic patients.
    Delamaire M; Maugendre D; Moreno M; Le Goff MC; Allannic H; Genetet B
    Diabet Med; 1997 Jan; 14(1):29-34. PubMed ID: 9017350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of thymus extracts on the chemotaxis of polymorphonuclear neutrophils (PMN) from patients with insulin-dependent diabetes mellitus (IDD).
    Wysocki J; Wierusz-Wysocka B; Wykretowicz A; Wysocki H
    Thymus; 1992 Aug; 20(1):63-7. PubMed ID: 1519313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polymorphonuclear neutrophil adhesion in patients with diabetes mellitus].
    Wierusz-Wysocka B; Wykretowicz A; Sadurska K; Lukomska E; Wysocki H
    Pol Tyg Lek; 1996 Jan; 51(1-5):11-3. PubMed ID: 8754291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High insulin enhances neutrophil transendothelial migration through increasing surface expression of platelet endothelial cell adhesion molecule-1 via activation of mitogen activated protein kinase.
    Okouchi M; Okayama N; Imai S; Omi H; Shimizu M; Fukutomi T; Itoh M
    Diabetologia; 2002 Oct; 45(10):1449-56. PubMed ID: 12378388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myeloperoxidase activity and glycogen levels in peripheral blood neutrophils in patients with well controlled diabetes mellitus type 1 and 2].
    Kołakowska-Polubiec K; Matuszewicz D; Starzyńska R; Polubiec M
    Pol Tyg Lek; 1988 Mar; 43(10):316-9. PubMed ID: 2841653
    [No Abstract]   [Full Text] [Related]  

  • 8. Intracytoplasmic cytokine levels and neutrophil functions in early clinical stage of type 1 diabetes.
    Bilgic S; Aktas E; Salman F; Ersahin G; Erten G; Yilmaz MT; Deniz G
    Diabetes Res Clin Pract; 2008 Jan; 79(1):31-6. PubMed ID: 17707941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.
    Lecomte P; Romon I; Fosse S; Simon D; Fagot-Campagna A
    Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assisting effects of lithium on hypoglycemic treatment in patients with diabetes.
    Hu M; Wu H; Chao C
    Biol Trace Elem Res; 1997; 60(1-2):131-7. PubMed ID: 9404682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characterisation of severe hypoglycaemia--a prospective population-based study.
    Holstein A; Plaschke A; Egberts EH
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):364-9. PubMed ID: 14520604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal counterregulation during severe hypoglycaemia under everyday conditions in patients with type 1 and insulin-treated type 2 diabetes mellitus.
    Holstein A; Hammer C; Plaschke A; Ptak M; Kuhn J; Diekmann J; Kleesiek K; Egberts EH
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):429-34. PubMed ID: 15372362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphonuclear leukocyte integrin profile in diabetes mellitus.
    Caimi G; Montana M; Citarrella R; Porretto F; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 2002; 27(2):83-9. PubMed ID: 12237478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphonuclear cell-mediated phagocytosis and superoxide anion release in insulin-dependent diabetes mellitus.
    Serlenga E; Garofalo AR; De Pergola G; Ventura MT; Tortorella C; Antonaci S
    Cytobios; 1993; 74(298-299):189-95. PubMed ID: 8404029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous glucose monitoring: physiologic and pathophysiologic significance.
    Ionescu-Tîrgovişte C; Guja C; Ioacără S; Dumitrescu D; Tomescu I
    Rom J Intern Med; 2004; 42(2):381-93. PubMed ID: 15529628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetes mellitus type II: when convert to insulin?].
    Bianda TL; Spinas GA
    Praxis (Bern 1994); 1997 Sep; 86(38):1453-7. PubMed ID: 9381045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of endogenous and environmental factors on variations of serum lipoprotein (a) concentrations in a large population of insulin-treated diabetic patients.
    Durlach V; Gillery P; Bertin E; Grulet H; Gross A; Leutenegger M
    Diabetes Metab; 1998 Apr; 24(2):124-30. PubMed ID: 9592636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus.
    Hashemi M; Naderi M; Rashidi H; Ghavami S
    Diabetes Res Clin Pract; 2007 Feb; 75(2):246-8. PubMed ID: 16875754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.